𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cryptic insertion of MLL gene into 9p22 leads to MLL–MLLT3 (AF9) fusion in a case of acute myelogenous leukemia

✍ Scribed by Mary Shago; Derek Bouman; Suzanne Kamel-Reid; Mark Minden; Kathy Chun


Book ID
102219894
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
177 KB
Volume
40
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The formation of a leukemogenic fusion product in hematopoietic malignancies is commonly achieved by chromosomal translocation. Alternate and cytogenetically undetectable mechanisms of fusion transcript generation have been documented for BCRAB1, AML1ETO, PMLRARA, NPM/ALK, and MLLMLLT2 (AF4). Here, we report the investigation of a cryptic rearrangement leading to MLLMLLT3 transcript formation. Cytogenetic analysis of peripheral blood from a 50‐year‐old acute myeloid leukemia patient yielded a karyotype of 47,XY,+8,del(11)(q21q23) in all metaphase cells examined. Metaphase fluorescence in situ hybridization analysis using the MLL probe at 11q23 revealed that the 5′ portion of the MLL gene was inserted into chromosome 9 at band p22, whereas the 3′ region of the MLL gene remained on chromosome 11. Whole‐chromosome paint analysis confirmed the cryptic transfer of chromosome 11 material to 9p22. With this information, the karyotype was reassigned as 47,XY,+8,der(9)ins(9;11)(p22;q23q23),del(11)(q21q23). RT‐PCR was used to show that the cryptic rearrangement in this patient led to the fusion of the MLL and MLLT3 transcripts on the der(9). The presence of the MLLMLLT3 transcript is consistent with the clinical findings in this patient. © 2004 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES